Viracta Therapeutics, Inc. (VIRX) Reports In-Line Q1 EPS

Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q1 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• HSBC Raises S&P500 Target to 8,100